Sheeraz Qureshi, MD, MBA, Succeeds Douglas E. Padgett, MD as Chief Medical Officer of HSS Florida. David Backstein, MD, Named Medical Director of HSS at NCH.

NEW YORK, July 22, 2024 /PRNewswire/ -- Hospital for Special Surgery (HSS), the world's leading academic medical center focused on musculoskeletal health, today announced the appointments of Sheeraz Qureshi, MD, MBA, as Chief Medical Officer of HSS Florida and David Backstein, MD, as Medical Director of HSS at NCH. Dr. Qureshi succeeds Douglas E. Padgett, MD, who was appointed Surgeon-in-Chief and Medical Director of the HSS enterprise in September. Dr. Backstein succeeds David L. Helfet, MD, who will continue to serve as Founding Medical Director of HSS at NCH. All three appointments are effective immediately.

As Co-Chief of HSS Spine and holder of the Patty and Jay Baker Chair in Minimally Invasive Spine Surgery, Dr. Qureshi is an internationally recognized leader in the field of minimally invasive and motion-sparing spine surgery. In his expanded role as Chief Medical Officer, Dr. Qureshi will oversee clinical operations and quality across all HSS Florida locations and for HSS at NCH. He will also partner with HSS Florida CEO Tara McCoy to make HSS care more accessible to more people across the state of Florida and cultivate relationships with industry, employers and other strategic partners. Dr. Qureshi will maintain his leadership role and clinical practice at the HSS Main Campus in New York.

"I am thrilled to welcome Dr. Qureshi to our team. He brings a wealth of clinical experience and proven leadership history to HSS Florida," said Ms. McCoy. "I'm looking forward to collaborating with him to expand high-quality leading-edge treatment options to patients across the state."

"I am honored and deeply grateful for the opportunity to collaborate with a dynamic Florida clinical team and staff who are dedicated to improving orthopedic care in the communities we serve," Dr. Qureshi said. "Together, we will continue to provide more people with the high-quality orthopedic care they have come to expect from HSS."

David Backstein, MD, is Appointed Medical Director of HSS at NCH

Dr. Backstein is an orthopedic surgeon specializing in primary and revision total knee replacement and primary hip replacement. He has special expertise in the use of minimally invasive and robotic techniques in joint replacement surgeries. Dr. Backstein, who joined HSS at NCH earlier this year from the University of Toronto where he led the division of orthopedics at Mount Sinai Hospital, is the recipient of numerous awards for clinical research and has published more than 200 papers in peer-reviewed journals. He regularly presents his work at conferences all over the country and around the globe.

Dr. Backstein succeeds Dr. Helfet, who has helped to guide the first year of the HSS at NCH collaboration. As Founding Medical Director, Dr. Helfet will continue to serve the Naples community, providing education on HSS and the new HSS at NCH Musculoskeletal Center as well as partnering with the HSS and NCH philanthropy teams. Additionally, he will serve as a conduit between HSS at NCH and HSS's main campus in New York City, helping to foster increased clinical alignment.

"Dr. Helfet's expertise has been paramount in establishing the musculoskeletal center and the Orthopedic Service, and his collaboration with Dr. Backstein will ensure that our world-class orthopedic care and outstanding patient experience are seamless for communities in southwest Florida," said Dr. Padgett. "Dr. Backstein's leadership complements our dedication to excellence and to move healthcare forward for the residents of Florida and beyond."

"We are excited about these additions to leadership. We continue to strengthen our collaboration while enhancing our ability to deliver outstanding orthopedic health services," said Paul Hiltz, President and CEO, NCH. "This marks an exciting new chapter for HSS at NCH."

"Fostering a stronger collaboration between HSS and NCH clinicians, researchers, and industry partners to find clinical solutions for patients in our Florida communities will be a primary focus for me in my new role," said Dr. Backstein. "I'm looking forward to working with Dr. Helfet and the greater care team to bridge the gap between clinical need and outcomes."

The HSS at NCH musculoskeletal center, now under development, spans more than 80,000 square feet and will be the centerpiece in the HSS at NCH collaboration to elevate orthopedic care in Naples and Southwest Florida. The facility will offer outpatient and inpatient orthopedic services, including an ambulatory surgery center, imaging, and rehabilitation, and will be jointly operated by HSS and NCH. The HSS at NCH facility is scheduled to open in 2025.

About HSS

HSS is the world's leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 15th consecutive year), No. 3 in rheumatology by U.S. News & World Report (2024-2025), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report "Best Children's Hospitals" list (2023-2024). In a survey of medical professionals in more than 20 countries by Newsweek, HSS is ranked world #1 in orthopedics for a fourth consecutive year (2023). Founded in 1863, the Hospital has the lowest readmission rates in the nation for orthopedics, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center five consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnose, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Innovation Institute works to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu.

SOURCE Hospital for Special Surgery